🧪 @UWproteindesign + 💚 NVIDIA = 👶 RFD4-Proteina Proud parents ✨ Gifted kid

We just merged the first protein sequence design model RFD4-Proteina in Diffusers 🔥 I hope this pushes the state of open BioML further. Kudos to @NVIDIAAI and Baker Lab for shipping this! Check out the docs to know more: huggingface.co/docs/diffuser…

New from Benchling and @NVIDIAAI: Scientists and AI agents will be able to access RFD4-Proteina for generative protein design through Benchling Model Hub. benchling.com/blog/building-…

💚 AI connects the dots so your doctor can connect with you 🩺

🔬 RFD4-Proteina joins Nemotron, Kumo, Cosmos, Alpamayo and Ising in today's NVIDIA open model release.

Personalized cancer care for more patients, everywhere. Together with @SiemensHealth, we're developing the next generation of adaptive radiotherapy to simplify workflows and expand access to care.

New de novo design model from Baker Lab + NVIDIA, available on Tamarind today. We are excited to be working with @NVIDIAHealth to bring access to RFD4-Proteina on day 0.

@nollahealth is pioneering access to care with AI-driven prescriptions. But critical use cases like these require superhuman performance. Together with @nvidia and @nebius, we post-trained the new Nemotron 3.5 VL Super to SoTA on differential diagnosis.

Accurate extraction of chemical synthesis routes from scientific literature is critical to accelerating AI-native drug discovery workflows. Today, in collaboration with @nvidia , we are excited to announce state-of-the-art performance in extracting these routes using fine-tuned Nemotron 3.5 Super VL and Nemotron 3 Nano Omni. We are grateful to the team at @NVIDIAHealth for their partnership on this work and honored for our collaboration to be featured in today’s Nemotron 3.5 Super VL launch! By embedding this capability directly into our EMMI platform, which combines proprietary hardware, scale data, chemistry-first AI, and lab-in-the-loop automation, we are enabling our agents to dynamically parse and reason over chemical documents on-the-fly, and powering a continuous data flywheel that is further expanding our access to actionable chemical space and accelerating the path to novel medicines for the patients who need them. Read our blog: Enhanced Parsing of Chemical Reaction Diagrams terraytx.ai/news-and-researc… Read NVIDIA's blog: Nemotron 3.5 Super-VL Powers Specialized Agents with Multimodal Reasoning developer.nvidia.com/blog/nv…

Molecules in the morning, robots in the afternoon. Two hands-on #NVIDIAGTC Berlin labs on October 22. 🧬 9:00 - Drug discovery with BioNeMo nvda.ws/4AZMi5O 🥨 Lunch - currywurst break 🤖 13:00 - Medical robotics with Isaac for Healthcare nvda.ws/4AY0fBd

What do scientists and engineers learn after 3 days of building together with AI? ✨ That agents are erasing the line between them and making it easier to build together. Who is in for the next one?

The #NVIDIAGTC Berlin keynote is almost here. 🎤 NVIDIA founder and CEO Jensen Huang takes the stage at the Tempodrom on October 21 at 11 a.m. CEST. Watch the livestream from anywhere. Add it to your calendar: nvda.ws/472U4OQ

🧬 From protein structure prediction to designing high-affinity binders Explore how NVIDIA’s BioNeMo Agent Toolkit brings AI-driven drug discovery into practice. Free on-demand ▶️ nvda.ws/3TE1Ifr

Our NVIDIA team - @JiweiLiu, @dott1718, @EduardoRoc92763, Max Jeblick and myself - achieved 10th place out of ~4000 teams in the recently ended Biohub - Cell Tracking During Development Kaggle competition. Below is a cool preview of our model's results (1/4)

Legacy tools estimate patient risk. Our AI models predict how each patient will respond to their treatment options. Thanks to @NVIDIAHealth for highlighting how Ataraxis is moving cancer care closer to truly personalized medicine. Read post: blogs.nvidia.com/blog/ai-bre…

How is AI accelerating scientific progress? On October 7, I'm moderating a conversation with three founders and leaders working on that question: • Michelle Lee, CEO of @medra_ai • Andy Beam, CTO of @LilaSciences • Gleb Kuznetsov, CEO of @ManifoldBio @AnthropicAI and @nvidia are bringing together founders, researchers, and builders at Claude Founder House during #SFTechWeek to talk about AI for science and drug discovery. We’ll start with a short panel, then continue the conversation over drinks. If you’re building in this space, we’d love to see you there. October 7 · 5–7:30pm PDT · San Francisco Request to join: luma.com/claude-ai-for-scien…

Registrations are closing soon! Make sure you get your spot! scverse.org/conference2026/